Fournier N, Doillon C J
Saint-François d'Assise Hospital, Department of Surgery, Laval University, Québec, Canada.
Biomaterials. 1996 Sep;17(17):1659-65. doi: 10.1016/0142-9612(96)87645-9.
Specific extracellular matrix molecules and growth factors (GFs) with angiogenic properties could be combined with biomaterials to enhance angiogenesis and subsequently tissue ingrowth through the wall of the porous structure. In this study, composite fibrin matrices containing hyaluronic acid (HA), fibronectin (FN) and/or fibroblast growth factor-1 (FGF-1), FGF-2 and an endothelial cell growth supplement (ECGS) were adsorbed onto Dacron meshes which were then implanted subcutaneously in mice. The release from the implants and the tissue distribution of implanted GFs were determined in vivo using radiolabelled FGF-2. Angiogenesis was quantified by counting the number of capillaries present in each Dacron histological serial section. Radiolabelled GF was rapidly released from matrices and was absent from them by day 28. A very low percentage of the implanted radiolabelled GFs was found in the kidneys and livers of the animals. The number of microvessels formed within fibrin-impregnated samples was increased in the presence of HA and ECGS at 14 d and of FN and ECGS or FGF-2 at 28 d. FGF-1 had no direct effect on angiogenesis in our model. These results indicate that enhancement of vascularization within prosthesis mesh may be achieved by using fibrin as a support for angiogenic molecules such as HA, FN and FGFs.
具有血管生成特性的特定细胞外基质分子和生长因子(GFs)可与生物材料结合,以增强血管生成,并随后促进组织通过多孔结构壁向内生长。在本研究中,将含有透明质酸(HA)、纤连蛋白(FN)和/或成纤维细胞生长因子-1(FGF-1)、FGF-2以及内皮细胞生长补充剂(ECGS)的复合纤维蛋白基质吸附到涤纶网片上,然后将其皮下植入小鼠体内。使用放射性标记的FGF-2在体内测定植入物中GFs的释放情况以及植入的GFs在组织中的分布。通过计算每个涤纶组织学连续切片中存在的毛细血管数量来量化血管生成。放射性标记的GF从基质中迅速释放,到第28天时基质中已不存在。在动物的肾脏和肝脏中发现植入的放射性标记GFs的比例非常低。在含有HA和ECGS的情况下,14天时纤维蛋白浸渍样品中形成的微血管数量增加;在含有FN和ECGS或FGF-2的情况下,28天时微血管数量增加。在我们的模型中,FGF-1对血管生成没有直接影响。这些结果表明,通过使用纤维蛋白作为血管生成分子(如HA、FN和FGFs)的载体,可以实现假体网片内血管化的增强。